In the report, Morgan Stanley noted, “While organic sales of -2.4% (+0.5% ex-timing factors) may have been below consensus, we believe it was broadly in line with investor expectations. Given both higher pricing and perhaps ~200 bps of Easter timing benefit, Q2 should be much improved (MSe 4%) and offer a stronger normalized indicator across 1H. Cheese results were also encouraging, offsetting weakness across a number of other segments (we would hope to see a more balanced profile going forward).”